Kunle Odunsi

38.1k total citations · 5 hit papers
370 papers, 15.5k citations indexed

About

Kunle Odunsi is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Kunle Odunsi has authored 370 papers receiving a total of 15.5k indexed citations (citations by other indexed papers that have themselves been cited), including 167 papers in Immunology, 138 papers in Oncology and 104 papers in Molecular Biology. Recurrent topics in Kunle Odunsi's work include Immunotherapy and Immune Responses (114 papers), Immune Cell Function and Interaction (70 papers) and Ovarian cancer diagnosis and treatment (69 papers). Kunle Odunsi is often cited by papers focused on Immunotherapy and Immune Responses (114 papers), Immune Cell Function and Interaction (70 papers) and Ovarian cancer diagnosis and treatment (69 papers). Kunle Odunsi collaborates with scholars based in United States, Switzerland and Canada. Kunle Odunsi's co-authors include Shashikant Lele, Protul Shrikant, Junko Matsuzaki, Lloyd J. Old, Feng Qian, Sacha Gnjatic, Paulette Mhawech‐Fauceglia, Gerd Ritter, Christine B. Ambrosone and Rajesh R. Rao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Kunle Odunsi

354 papers receiving 15.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intraepithelial CD8⁺tumor-infiltrating lymphocytes and a high CD8⁺/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

2005 1.9k citations Feng Qian, Sacha Gnjatic et al. profile →
Tumor-infiltrating NY-ESO-1–specific CD8 ⁺ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer

2010 695 citations Junko Matsuzaki, Sacha Gnjatic et al. profile →
The mTOR Kinase Determines Effector versus Memory CD8+ T Cell Fate by Regulating the Expression of Transcription Factors T-bet and Eomesodermin

2010 516 citations Kunle Odunsi, Protul Shrikant et al. profile →
Gene expression markers of Tumor Infiltrating Leukocytes

2017 478 citations Kunle Odunsi et al. profile →
Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints

2015 380 citations Junko Matsuzaki, Jason B. Muhitch et al. profile →

Peers

Countries citing papers authored by Kunle Odunsi

Since Specialization

Citations

This map shows the geographic impact of Kunle Odunsi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kunle Odunsi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kunle Odunsi more than expected).

Fields of papers citing papers by Kunle Odunsi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kunle Odunsi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kunle Odunsi. The network helps show where Kunle Odunsi may publish in the future.

Co-authorship network of co-authors of Kunle Odunsi

This figure shows the co-authorship network connecting the top 25 collaborators of Kunle Odunsi. A scholar is included among the top collaborators of Kunle Odunsi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kunle Odunsi. Kunle Odunsi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	GEN-1 in Combination with Neoadjuvant Chemotherapy for Patients with Advanced Epithelial Ovarian Cancer: A Phase I Dose-escalation Study 2021 ·Clinical Cancer Research ·Premal H. Thaker, William H. Bradley, Charles A. Leath, (unknown), Nicholas Borys, Khursheed Anwer, (unknown), Junko Matsuzaki, Wiam Bshara, Kunle Odunsi, Ronald D. Alvarez	19
2	Quantification of Early-Stage Myeloid-Derived Suppressor Cells in Cancer Requires Excluding Basophils 2020 ·Cancer Immunology Research ·A. Nazmul H. Khan, Tiffany R. Emmons, Jerry Wong, (unknown), Kelly L. Singel, (unknown), (unknown), Joseph D. Tario, Kevin H. Eng, Kirsten B. Moysich, Kunle Odunsi, Scott I. Abrams, Brahm H. Segal	33
3	Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell Therapy 2018 ·Cancer Immunology Research ·Takemasa Tsuji, (unknown), Junko Matsuzaki, Anthony Miliotto, (unknown), Richard C. Koya, Kunle Odunsi	13
4	Exosomes Associated with Human Ovarian Tumors Harbor a Reversible Checkpoint of T-cell Responses 2018 ·Cancer Immunology Research ·Gautam N. Shenoy, Jenni Loyall, Orla Maguire, Vandana Iyer, Raymond J. Kelleher, Hans Minderman, Paul K. Wallace, Kunle Odunsi, Sathy V. Balu‐Iyer, Richard B. Bankert	60
5	Active Estrogen Receptor-alpha Signaling in Ovarian Cancer Models and Clinical Specimens 2017 ·Clinical Cancer Research ·Courtney L. Andersen, Matthew J. Sikora, M.M. Boisen, Tianzhou Ma, (unknown), George C. Tseng, Yongseok Park, Soumya Luthra, Uma Chandran, Paul Haluska, Gina Mantia-Smaldone, Kunle Odunsi, Karen McLean, Adrian V. Lee, Esther Elishaev, Robert P. Edwards, Steffi Oesterreich	38
6	NY-ESO-1 Vaccination in Combination with Decitabine Induces Antigen-Specific T-lymphocyte Responses in Patients with Myelodysplastic Syndrome 2017 ·Clinical Cancer Research ·Elizabeth A. Griffiths, Pragya Srivastava, Junko Matsuzaki, (unknown), Eunice S. Wang, (unknown), Austin Miller, Gregory W. Roloff, Hong Yuen Wong, Benjamin E. Paluch, (unknown), (unknown), Kunle Odunsi, Adam R. Karpf, Christopher S. Hourigan, Michael J. Nemeth	76
7	A Pilot Study of Stereotactic Body Radiation Therapy Combined with Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma 2017 ·Clinical Cancer Research ·Anurag K. Singh, (unknown), Mohammad Habiby Kermany, (unknown), (unknown), Austin Miller, (unknown), Leighton C. Stein, Lalith K. Kumaraswamy, Graham Warren, Wiam Bshara, Kunle Odunsi, Junko Matsuzaki, Scott I. Abrams, Thomas Schwaab, Jason B. Muhitch	65
8	DNA Methylome Analyses Implicate Fallopian Tube Epithelia as the Origin for High-Grade Serous Ovarian Cancer 2016 ·Molecular Cancer Research ·David Klinkebiel, Wa Zhang, Stacey N. Akers, Kunle Odunsi, Adam R. Karpf	36
9	Synergistic COX2 Induction by IFNγ and TNFα Self-Limits Type-1 Immunity in the Human Tumor Microenvironment 2016 ·Cancer Immunology Research ·Jeffrey L. Wong, Nataša Obermajer, Kunle Odunsi, Robert P. Edwards, Paweł Kaliński	51
10	Extracellular Vesicles Present in Human Ovarian Tumor Microenvironments Induce a Phosphatidylserine-Dependent Arrest in the T-cell Signaling Cascade 2015 ·Cancer Immunology Research ·Raymond J. Kelleher, Sathy V. Balu‐Iyer, Jenni Loyall, (unknown), Gautam N. Shenoy, Peng Peng, Vandana Iyer, (unknown), Charles S. Berenson, Paul K. Wallace, Joseph D. Tario, Kunle Odunsi, Richard B. Bankert	93
11	Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian Cancer 2014 ·Cancer Immunology Research ·Kunle Odunsi, Junko Matsuzaki, Smitha R. James, Paulette Mhawech‐Fauceglia, Takemasa Tsuji, Austin Miller, Wa Zhang, Stacey N. Akers, Elizabeth A. Griffiths, Anthony Miliotto, Amy Beck, Carl A. Batt, Gerd Ritter, Shashikant Lele, Sacha Gnjatic, Adam R. Karpf	153
12	Induction and stability of human Th17 cells require endogenous NOS2 and cGMP-dependent NO signaling 2013 ·The Journal of Experimental Medicine ·Nataša Obermajer, Jeffrey L. Wong, Robert P. Edwards, Kong Chen, Melanie J. Scott, Shabaana A. Khader, Jay K. Kolls, Kunle Odunsi, Timothy R. Billiar, Paweł Kaliński	93
13	Nonclassical Antigen-Processing Pathways Are Required for MHC Class II–Restricted Direct Tumor Recognition by NY-ESO-1–Specific CD4+ T Cells 2013 ·Cancer Immunology Research ·Junko Matsuzaki, Takemasa Tsuji, Immanuel F. Luescher, Lloyd J. Old, Protul Shrikant, Sacha Gnjatic, Kunle Odunsi	38
14	CXCR3+ T Regulatory Cells Selectively Accumulate in Human Ovarian Carcinomas to Limit Type I Immunity 2012 ·Cancer Research ·(unknown), Caroline Raffin, Isabelle Raimbaud, Pascale Pignon, Junko Matsuzaki, Kunle Odunsi, Danila Valmori, Maha Ayyoub	125
15	A Small-Molecule Inhibitor Targeting the Mitotic Spindle Checkpoint Impairs the Growth of Uterine Leiomyosarcoma 2012 ·Clinical Cancer Research ·(unknown), (unknown), Kari J. Brewer Savannah, (unknown), (unknown), Dafydd G. Thomas, Kunle Odunsi, Chad J. Creighton, Dina Lev, Matthew L. Anderson	49
16	PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment 2011 ·Cancer Research ·Nataša Obermajer, Ravikumar Muthuswamy, Kunle Odunsi, Robert P. Edwards, Paweł Kaliński	377
17	Coordinated Cancer Germline Antigen Promoter and Global DNA Hypomethylation in Ovarian Cancer: Association with the BORIS/CTCF Expression Ratio and Advanced Stage 2011 ·Clinical Cancer Research ·Anna Woloszynska‐Read, Wa Zhang, Jihnhee Yu, Petra A. Link, Paulette Mhawech‐Fauceglia, (unknown), Stacey N. Akers, Kelly R. Ostler, Lucy A. Godley, Kunle Odunsi, Adam R. Karpf	68
18	Microarray analysis reveals distinct gene expression profiles among different tumor histology, stage and disease outcomes in endometrial adenocarcinoma. 2010 ·SHILAP Revista de lepidopterología ·Paulette Mhawech‐Fauceglia, (unknown), Joshua P. Kesterson, Kimberly Clark, (unknown), Kunle Odunsi, Shashikant Lele, Song Liu	2
19	Efficacy of Levo-1-Methyl Tryptophan and Dextro-1-Methyl Tryptophan in Reversing Indoleamine-2,3-Dioxygenase–Mediated Arrest of T-Cell Proliferation in Human Epithelial Ovarian Cancer 2009 ·Cancer Research ·Feng Qian, Jeannine Villella, Paul K. Wallace, Paulette Mhawech‐Fauceglia, Joseph D. Tario, Chris Andrews, Junko Matsuzaki, Danila Valmori, Maha Ayyoub, Peter J. Frederick, Amy Beck, Jianqun Liao, Richard Cheney, Kirsten B. Moysich, Shashikant Lele, Protul Shrikant, Lloyd J. Old, Kunle Odunsi	118
20	Intertumor and Intratumor NY-ESO-1 Expression Heterogeneity Is Associated with Promoter-Specific and Global DNA Methylation Status in Ovarian Cancer 2008 ·Clinical Cancer Research ·Anna Woloszynska‐Read, Paulette Mhawech‐Fauceglia, Jihnhee Yu, Kunle Odunsi, Adam R. Karpf	87

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact